# Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque

> **NCT01873716** · PHASE1 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 5 (actual)

## Conditions studied

- Atherosclerosis
- Atherosclerotic Plaque
- Carotid Stenosis

## Interventions

- **DRUG:** Indocyanine green

## Key facts

- **NCT ID:** NCT01873716
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2017-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01873716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01873716, "Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01873716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*